Lead Product(s) : Bexarotene
Therapeutic Area : Neurology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Bexarotene is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 13, 2014
Lead Product(s) : Bexarotene
Therapeutic Area : Neurology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bexarotene
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Genentech | Ligand Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Targretin (Bexarotene) is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Head and Neck Neoplasms.
Product Name : Targretin
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 05, 2010
Lead Product(s) : Bexarotene
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Genentech | Ligand Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
